The Comprehensive Hematology & Oncology Review Course (CORC) is a broad review of the latest data, guidelines, recommendations and recent advances in therapeutic options in hematology and medical oncology standards of care.
Intended Audience
This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, allied health professionals, residents, and fellows interested in a comprehensive update on solid tumors and hematologic disorders and will be of interest to those certifying or re-certifying for their boards.
Learning Objectives
Upon completion of this activity, learners should be able to:
Explain the pathogenesis, diagnostic evaluation and therapeutic modalities available for common solid tumor malignancies.
Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
Organize new therapeutic and diagnostic approaches into clinical practice as appropriate.
Course Information
This course is chaired by Ryan Cassaday, MD and Molly Tokaz, MD.
Registration
Registration is required. The registration deadline is June 30, 2026.
Access Instructions
Learners have access to this virtual, on-demand course via the UW CME website December 4, 2025 through November 30, 2026. Presentation slides are available to learners for each topic.
Learners will receive instructions for accessing the material in their confirmation email. Access to the internet is required to complete this training.
Accreditation
The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 34.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.